These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin. Appelbaum PC, Gillespie SH, Burley CJ, Tillotson GS. Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123 [Abstract] [Full Text] [Related]
3. Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability. Lode H, File TM, Mandell L, Ball P, Pypstra R, Thomas M, 185 Gemifloxacin Study Group. Clin Ther; 2002 Nov; 24(11):1915-36. PubMed ID: 12501883 [Abstract] [Full Text] [Related]
4. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Wilson R, Schentag JJ, Ball P, Mandell L, 068 Study Group. Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408 [Abstract] [Full Text] [Related]
10. Efficacy of gemifloxacin in acute exacerbations of chronic bronchitis: a randomised, double-blind comparison with trovafloxacin. Ball P, Wilson R, Mandell L, Brown J, Henkel T, 069 Clinical Study Group. J Chemother; 2001 Jun; 13(3):288-98. PubMed ID: 11450888 [Abstract] [Full Text] [Related]
11. Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group. File T, Schlemmer B, Garau J, Lode H, Lynch S, Young C. J Chemother; 2000 Aug; 12(4):314-25. PubMed ID: 10949981 [Abstract] [Full Text] [Related]
12. Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis. Wilson R, Langan C, Ball P, Bateman K, Pypstra R, Gemifloxacin 207 Clinical Study Group. Respir Med; 2003 Mar; 97(3):242-9. PubMed ID: 12645831 [Abstract] [Full Text] [Related]
15. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group. O'Doherty B, Daniel R. Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):441-6. PubMed ID: 9758290 [Abstract] [Full Text] [Related]
18. Gemifloxacin for community-acquired pneumonia. Lode HM, Schmidt-Ionas M, Stahlmann R. Expert Opin Investig Drugs; 2008 May; 17(5):779-86. PubMed ID: 18447602 [Abstract] [Full Text] [Related]
19. Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials. Zhang L, Wang R, Falagas ME, Chen LA, Liu YN. Chin Med J (Engl); 2012 Feb; 125(4):687-95. PubMed ID: 22490497 [Abstract] [Full Text] [Related]